Showing results (1051-1060 of 4,380) with videos related to

Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|July 21, 2016
Discovery of MK-8718, an HIV Protease Inhibitor Containing a Novel Morpholine Aspartate Binding GroupChristopher J Bungard, Peter D Williams, Jeanine E Ballard, et al.
ACS Medicinal Chemistry Letters|July 21, 2016
Novel Series of Potent Glucokinase Activators Leading to the Discovery of AM-2394Paul J Dransfield, Vatee Pattaropong, Sujen Lai, et al.
ACS Medicinal Chemistry Letters|July 21, 2016
Discovery of Phosphodiesterase 10A (PDE10A) PET Tracer AMG 580 to Support Clinical StudiesEssa Hu, Ning Chen, Roxanne K Kunz, et al.
ACS Medicinal Chemistry Letters|April 21, 2015
F-18 Labeled RGD Probes Based on Bioorthogonal Strain-Promoted Click Reaction for PET ImagingHye Lan Kim, Kalme Sachin, Hyeon Jin Jeong, et al.
ACS Medicinal Chemistry Letters|April 21, 2015
PNA-Based Multivalent Scaffolds Activate the Dopamine D2 ReceptorAndrew V Dix, Jennie L Conroy, Kara M George Rosenker, et al.
ACS Medicinal Chemistry Letters|April 21, 2015
Discovery of a Novel Series of Thienopyrimidine as Highly Potent and Selective PI3K InhibitorsFangbin Han, Songwen Lin, Peng Liu, et al.
ACS Medicinal Chemistry Letters|April 21, 2015
Azolylthioacetamide: A Highly Promising Scaffold for the Development of Metallo-β-lactamase InhibitorsShao-Kang Yang, Joon S Kang, Peter Oelschlaeger, et al.
ACS Medicinal Chemistry Letters|July 16, 2020
Exploiting Existing Molecular Scaffolds for Long-Term COVID TreatmentKrishna Kumar, Tania J Lupoli
ACS Medicinal Chemistry Letters|July 16, 2020
Advantages of the Parent Nucleoside GS-441524 over Remdesivir for Covid-19 TreatmentVictoria C Yan, Florian L Muller
ACS Medicinal Chemistry Letters|June 24, 2015
Generation of Broad-Spectrum Antifungal Drug Candidates from the Natural Product Compound Aureobasidin APeter G M Wuts, Lloyd J Simons, Brian P Metzger, et al.
Pageof 438